Dr. Reddy's Laboratories Limited has informed the Exchange regarding Change in Director(s) of the company.

Management Changes View source PDF Explain this filing

DRREDDY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.6%Reaction day

₹1268.90

prior close

₹1266.00

announcement price

After-mkt

timing

Nifty 100market · index membership as recorded later (tracked since Jun 2026)-1.0%+1.6% vs market

Pharmaceuticals peers, median of 149sector-1.0%+1.6% vs sector

On the reaction day the stock moved 1.6 pts more than Nifty 100 and 1.6 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.5

10m

+1.2

15m

+1.3

30m

+1.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.6-1.0+1.6-1.0+1.6

Next day

+1.4-1.6+3.0-1.7+3.2

+2.5-1.0+3.5-0.8+3.3

+1.8-0.9+2.7-0.8+2.6

-0.1-1.3+1.1-1.6+1.5

-3.7-2.1-1.6-3.6-0.1

-4.3-1.7-2.6-3.3-1.0

15d

-0.5-0.8+0.4-4.9+4.4

+1.0-0.4+1.5-4.6+5.6

+0.5-0.5+1.0-4.8+5.2

+1.3+3.4-2.1-7.9+9.2

UpDownMarket · Nifty 100Sector · Pharmaceuticals peers, median of 149Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Shareholders of Dr. Reddy's Laboratories have approved the re-appointment of Mr. G V Prasad (DIN: 00057433) as Whole-Time Director designated as Co-Chairman and Managing Director at the 41st AGM held on July 24, 2025. The re-appointment is for a 5-year term, effective from January 30, 2026 to January 29, 2031. The Board had earlier recommended this at its meeting on May 9, 2025. Mr. Prasad is one of the company's promoters with 36+ years of pharmaceutical industry leadership experience and is brother-in-law of Chairman Mr. K Satish Reddy.

Likely market impact

Continuity at the top leadership level with an existing promoter-family director, which provides stability but keeps the senior management within the founding family. This is a procedural re-appointment, not a change, so limited direct impact on the stock is expected.